Benztropine Mesylate Tablet
Product Images NDC 10135-813

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 10135-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceutical, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

813-01 (813 01)

This is a label for Benztropine Mesylate Tablets, USP containing 100 tablets. The usual adult dosage is mentioned for parkinsonism. It advises keeping the tablets out of reach of children and storing them at a temperature range of 20 to 25°C (68 to 77°F). Additionally, the label is dated with a revision date of 03/25.*

FDA Label Image

813-10 (813 10)

This text provides information about a medication labeled NDC 10135-0813-10 containing Benztropine Mesylate, USP 0.5mg. The usual adult dosage is described for parkinsonism and drug-induced extrapyramidal disorders. The tablets should be kept in a well-closed container at a specific range of temperatures. The medication is manufactured for/distributed by Marlex Pharmaceuticals, Inc.*

FDA Label Image

814-01 (814 01)

FDA Label Image

814-10 (814 10)

This is a description of a medication with the NDC 10135-0814-10. Each tablet contains 1mg of Benztropine Mesylate, USP. The usual adult dosage for Parkinsonism is 10-20mg daily, while for drug-induced extrapyramidal disorders it is 10-40mg once or twice a day. The medication should be kept in a well-closed container at 20° to 25°C and should be kept out of reach of children. The pharmaceuticals are manufactured and distributed by Marlex Pharmaceuticals, Inc.*

FDA Label Image

815-01 (815 01)

FDA Label Image

815-10 (815 10)

The text provides information about Boplie tablets containing Benztopine Mesylate USP 2mg. It suggests the usual adult dosage for Parkinsonism and drug-induced extrapyramidal disorders. It also mentions storage instructions and warnings about keeping the drug out of reach of children. The tablets are distributed by Marlex Pharmaceuticals, Inc.*

FDA Label Image

C1789516-figure-01 (C1789516 Figure 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.